Molecular neuro-oncologist David Solomon, MD, PhD, has reached a unique and impressive milestone: the publication of his team's 50th research study stemming from the UCSF500 Cancer Gene Panel. In a Q&A, Solomon reflects on the scientific impact of these studies and their implications for present and future neuro-oncology treatment. [read more]
|
|
|
|
Mitchel Berger, MD, neurosurgeon and director of the UCSF Brain Tumor Center, discusses how precision medicine and other breakthroughs in brain tumor treatment at UCSF contribute to the Cancer Moonshot’s goal of ending cancer as we know it. |
|
|
|
A team led by Lena Winestone, MD, delves into racial and ethnic disparities in outcomes for Black and Hispanic children with acute leukemia. The study, published in BMC Cancer, looks at factors underpinning delays in diagnosis. |
|
Bay Area Breast Cancer Forum |
|
|
|
Watch the latest episode of Bay Area Breast Cancer Forum in which Dr. Hope Rugo and Dr. Donald Abrams explore the topic of "Integrative Cancer Care in Breast Cancer." |
|
Lydia Zablotska, MD, MPA, PhD was awarded funding for a project, “Verification and Correction of early Atomic Energy of Canada Limited doses in the National Dose Registry and Updated Mortality (1950–2018) and Cancer Incidence (1969–2018) Analysis of Canadian Nuclear Energy Workers.”
|
|
Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, Glas AM, Witteveen A, Cardoso F, Piccart M, Esserman LJ, Poncet C, van 't Veer LJ. Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial. J Clin Oncol. 2022 Apr 20;40(12):1335-1345. |
|
June 25, 2022 | 10:00 am - 12:00 pm
This event aims to honor and continue the work of Frank Staggers, Sr., MD, a urologist and visionary leader in Alameda County and across the Bay Area. Join us to hear from expert speakers and advocates and get your questions answered!
|
|
|
June 1, 2022 | 4:00 - 5:30 pm
Panel discussion with admission directors from medical schools, nursing, and physician assistant programs throughout California. Each will give advice and answer your questions. Open to all HDFCCC staff. Register to attend.
|
|
|
Part of the HDFCCC K12 Physician Scientist Program in Clinical Oncology, these three series are open to all senior fellows and early career faculty. Learn more and register.
- Concept to Completion: Strategies for Successful Clinical Trials
- Leadership and Career Development Seminar
- Clinically Driven Discovery Science in Cancer: From Bench to Bedside
|
|
A virtual celebration to recognize Clinical Research Coordinators (CRCs) and their many contributions to UCSF's research enterprise.
Get to know Suresh Gunasekaran, the new President and CEO at UCSF Health and a top API leader at UCSF.
Kornelia Polyak, MD, PhD (Harvard) will present, "Immune Escape in Breast Cancer."
Dr. Eliseo Pérez-Stable, director of the National Institute on Minority Health and Health Disparities will present, "How Science can Promote Health Equity."
|
|
|
|
|
|
|
